top of page

Pharma Services M&A Valuation Segment Report

Comparable Transactions / Precedent Deals


Excel spreadsheet wth Scope Research's pharma services M&A valuation data and benchmarking tools. Transactions involve a mixture of CRO, CDMO, consulting, commercialization, and other pharmaceutical services organizations of different sizes.


  • 136 transactions with revenue or EBITDA multiples (since 2010)
  • 112 of these deals have reported EBITDA Multiples
  • Last updated 2/2/24


Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented. 

Reach out to for more information.

All transactions included in the Scope Research healthcare M&A databases are meticulously researched and sourced from public documentation. Our internal records include an audit trail of links to our sources, which include:

  • Fairness opinions
  • SEC filings
  • Press releases
  • Bond market research
  • Medicare cost reports
  • CON filings (FOIA)
  • Form 990s
  • Public audits
  • AG reports
  • Insurance department filings

Pharmaceutical Services

    bottom of page